Corteva, through its Corteva Catalyst platform launched in 2024, serves as the corporate venture and strategic investment arm of Corteva Agriscience, a publicly traded global agriculture company. The platform makes equity investments and forms strategic partnerships in agricultural technology startups, focusing on gene editing, biologicals and natural products, technology platforms, and decision science, with typical check sizes of $10 million or less across stages from pre-seed through Series C.
50% of their portfolio is in Food & Agriculture. Deal activity increased 100% year-over-year (2 deals in the last 12 months). Average disclosed round size is $51.8M (across 5 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Audrey Grimm
Senior Vice President, Chief People Officer
Brook Cunningham
Senior Vice President of Corteva and President, Corteva Asia-Pacific
David Johnson
Executive Vice President, Chief Financial Officer
Jeff Rudolph
Senior Vice President, Chief Strategy Officer
Jennifer A. Johnson
Senior Vice President, Chief Legal and Public Affairs Officer, Corporate Secretary
Judd O’Connor
Executive Vice President, Seed Business Unit
Sam Eathington
Executive Vice President, Chief Technology and Digital Officer
Chuck Magro
Chief Executive Officer
Luke Kissam
Chief Executive Officer of the Corteva Crop Protection Business
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Tropic | Series C | $105M | Mar 2026 |
| TTropic Biosciences | Bridge | $105M | Mar 2026 |
| MMicropep Technologies | Series B | $29M | Sep 2024 |
 Resurrect Bio | Series A | $8.1M | — |
 Ascribe Bioscience | Series A | $12M | — |
 Rainbow Crops | Seed | — | — |
Top Co-Investors
Last updated: 8 September 2026